Home / Market News / $HSTM
benzinga Corporate Catalyst Impact 92/100 ● positive

HealthStream Q2 EPS $0.23 Beats $0.17 Estimate, Sales $83.732M Beat $80.827M Estimate

Aug 3, 2026, 8:31 PM UTC · Primary ticker $HSTM

HealthStream reported strong Q2 earnings and sales, significantly exceeding analyst expectations. This positive performance indicates robust operational health and could lead to increased investor confidence and upward stock price movement in the short term.

HealthStream's Q2 earnings of $0.23 per share significantly beat the analyst consensus of $0.17, representing a 35.29% beat and a 27.78% increase year-over-year. Sales also exceeded expectations, coming in at $83.732 million against an $80.827 million estimate, a 3.59% beat and a 12.55% increase from the prior year. This strong financial performance indicates healthy growth and operational efficiency, which is highly positive for the company and its investors. For traders, this suggests a potential short-term upward movement in HSTM's stock price as the market reacts to the better-than-expected results, potentially leading to increased buying interest and a re-evaluation of the company's valuation.

$HSTM positive Strong Q2 earnings and sales beat
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.